Engert A - Search Results

1

Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.

Tesch H, Diehl V, Lathan B, Hasenclever D, Sieber M, Rüffer U, Engert A, Franklin J, Pfreundschuh M, Schalk KP, Schwieder G, Wulf G, Dölken G, Worst P, Koch P, Schmitz N, Bruntsch U, Tirier C, Müller U, Loeffler M. Tesch H, et al. Among authors: engert a. Blood. 1998 Dec 15;92(12):4560-7. Blood. 1998. PMID: 9845521 Free article. Clinical Trial.

2

Experimental therapy in Hodgkin's disease.

Engert A, Pohl C, Diehl V. Engert A, et al. Ann Oncol. 1992 Sep;3 Suppl 4:97-100. doi: 10.1093/annonc/3.suppl_4.s97. Ann Oncol. 1992. PMID: 1333274

3

An overview of the Second International Symposium on Hodgkin's disease.

Diehl V, Engert A. Diehl V, et al. Among authors: engert a. Ann Oncol. 1992 Sep;3 Suppl 4:1-3. doi: 10.1093/annonc/3.suppl_4.s1. Ann Oncol. 1992. PMID: 1360252 No abstract available.

4

Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised mice.

Kapp U, Wolf J, von Kalle C, Tawadros S, Röttgen A, Engert A, Fonatsch C, Stein H, Diehl V. Kapp U, et al. Among authors: engert a. Ann Oncol. 1992 Sep;3 Suppl 4:21-3. doi: 10.1093/annonc/3.suppl_4.s21. Ann Oncol. 1992. PMID: 1450076

5

[New perspectives in oncology: is selective destruction of tumor cells with immunotoxins in Hodgkin's disease an additional therapeutic alternative?].

Engert A, Gottstein C, Winkler U, Schön G, Amlot P, Thorpe P, Diehl V. Engert A, et al. Med Klin (Munich). 1992 Oct 15;87(10):503-9. Med Klin (Munich). 1992. PMID: 1461215 Review. German.

6

Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.

Engert A, Martin G, Pfreundschuh M, Amlot P, Hsu SM, Diehl V, Thorpe P. Engert A, et al. Cancer Res. 1990 May 15;50(10):2929-35. Cancer Res. 1990. PMID: 1692251

7

Controversies in the management of non-Hodgkin lymphoma.

Engert A, Diehl V. Engert A, et al. Eur J Cancer. 1991;27(3):309-15. doi: 10.1016/0277-5379(91)90536-m. Eur J Cancer. 1991. PMID: 1827323 Review. No abstract available.

8

[Non-Hodgkin lymphoma and pregnancy].

Engert A, Lathan B, Cremer R, Seeber S, Schulte M, Diehl V. Engert A, et al. Med Klin (Munich). 1990 Dec 15;85(12):734-8. Med Klin (Munich). 1990. PMID: 2087215 German. No abstract available.

9

Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.

Engert A, Burrows F, Jung W, Tazzari PL, Stein H, Pfreundschuh M, Diehl V, Thorpe P. Engert A, et al. Cancer Res. 1990 Jan 1;50(1):84-8. Cancer Res. 1990. PMID: 2152774

10

Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody.

Sahin U, Hartmann F, Senter P, Pohl C, Engert A, Diehl V, Pfreundschuh M. Sahin U, et al. Among authors: engert a. Cancer Res. 1990 Nov 1;50(21):6944-8. Cancer Res. 1990. PMID: 2170012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters